Oct-2023
2022 Synapse Cluster Report: A Year of Breakthroughs and Boundless Possibilities for Hamilton’s Life Sciences Cluster
HAMILTON, ONTARIO – The Synapse Life Science Consortium is pleased to announce the release of the 2022 Hamilton Life Science Cluster Report. The report highlights another year of remarkable growth and groundbreaking achievements in 2022. With transformational research and innovations fueling commercial endeavors, Hamilton continues to hold its reputation as a hub for life sciences innovation.
The 2022 Cluster Report summarizes the dynamic growth of the Hamilton life sciences ecosystem, highlighting the integration of organizations that contribute to its vibrant community. Central to this development is Hamilton’s exceptional research foundation. With institutions such as McMaster University at its helm and the significant contributions from Hamilton Health Sciences and St. Joseph’s Healthcare Hamilton, the city remains a focal point for innovative breakthroughs in life sciences.
Among the year’s many standout stories include the arrival of OmniaBio Inc. which leveraged a $40 Million investment from the province of Ontario to build a 200,000-square-foot, $580-million facility, creating Canada’s largest CDMO, exclusively manufacturing cell and gene therapy. Simultaneously, Hamilton-based, life sciences startup ToeFX celebrated serving 100 clinics nationwide, from British Columbia to Newfoundland.
Hamilton has made significant progress in global health by pioneering advancements in infectious diseases, personalized medicine, and medical device innovation “Hamilton’s success is a testament to the tenacity, collaboration, and unyielding spirit of its researchers, entrepreneurs, and healthcare centres. Together, they’ve not only put Hamilton on the global map but also set the gold standard for life sciences innovation,” stated Alex Muggah, Director of the Synapse Consortium.
To read the 2022 Synapse Cluster report, please visit:
About Synapse Life Science Consortium
The formal regional cluster organization for the life sciences ecosystem in the greater Hamilton region, the Synapse Consortium acts as a strategic broker for the community, with the goal of supporting the commercialization of innovative health technology. Synapse partners include the anchor life science organizations in Hamilton, representing 45,000 employees and nearly $500 million in annual innovative research. Innovation Factory was a founding member of Synapse in 2016, along with Hamilton Health Sciences, St. Joseph’s Healthcare Hamilton, McMaster University, Mohawk College, Bay Area Health Trust, McMaster Innovation Park, City of Hamilton.
About Innovation Factory
Innovation Factory is a not-for-profit business accelerator, serving as the catalyst for technology innovation in the greater Hamilton area since 2010. Innovation Factory provides business services, training, mentorship, and strategic connections to drive market adoption, leverage intellectual property, and increase revenues, investment, and jobs. Innovators can also access sector-specific resources including exclusive smart transportation test environments and data; and a formal life science and health innovation ecosystem.